Malignancies and ustekinumab: an analysis of the U.S. Food and Drug Administration Adverse Event Reporting System and the European Union Drug Regulating Authorities Pharmacovigilance database

A. G. Florek; B. Nardone; S. Thareja; G. Tran; Francis Joseph Giles; D. P. West

doi:10.1111/bjd.15752

Malignancies and ustekinumab: an analysis of the U.S. Food and Drug Administration Adverse Event Reporting System and the European Union Drug Regulating Authorities Pharmacovigilance database

A. G. Florek, B. Nardone, S. Thareja, G. Tran, Francis Joseph Giles, D. P. West^*

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

12 Scopus citations

Original language	English (US)
Pages (from-to)	e220-e221
Journal	British Journal of Dermatology
Volume	177
Issue number	5
DOIs	https://doi.org/10.1111/bjd.15752
State	Published - Nov 2017

ASJC Scopus subject areas

Dermatology

Access to Document

10.1111/bjd.15752

Cite this

@article{3897a6206a1247488d51678bf4e23546,

title = "Malignancies and ustekinumab: an analysis of the U.S. Food and Drug Administration Adverse Event Reporting System and the European Union Drug Regulating Authorities Pharmacovigilance database",

author = "Florek, {A. G.} and B. Nardone and S. Thareja and G. Tran and Giles, {Francis Joseph} and West, {D. P.}",

year = "2017",

month = nov,

doi = "10.1111/bjd.15752",

language = "English (US)",

volume = "177",

pages = "e220--e221",

journal = "British Journal of Dermatology",

issn = "0007-0963",

publisher = "Wiley-Blackwell",

number = "5",

}

Malignancies and ustekinumab: an analysis of the U.S. Food and Drug Administration Adverse Event Reporting System and the European Union Drug Regulating Authorities Pharmacovigilance database. / Florek, A. G.; Nardone, B.; Thareja, S. et al.
In: British Journal of Dermatology, Vol. 177, No. 5, 11.2017, p. e220-e221.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Malignancies and ustekinumab

T2 - an analysis of the U.S. Food and Drug Administration Adverse Event Reporting System and the European Union Drug Regulating Authorities Pharmacovigilance database

AU - Florek, A. G.

AU - Nardone, B.

AU - Thareja, S.

AU - Tran, G.

AU - Giles, Francis Joseph

AU - West, D. P.

PY - 2017/11

Y1 - 2017/11

UR - http://www.scopus.com/inward/record.url?scp=85035795024&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85035795024&partnerID=8YFLogxK

U2 - 10.1111/bjd.15752

DO - 10.1111/bjd.15752

M3 - Letter

C2 - 28646575

AN - SCOPUS:85035795024

SN - 0007-0963

VL - 177

SP - e220-e221

JO - British Journal of Dermatology

JF - British Journal of Dermatology

IS - 5

ER -

Malignancies and ustekinumab: an analysis of the U.S. Food and Drug Administration Adverse Event Reporting System and the European Union Drug Regulating Authorities Pharmacovigilance database

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this